Pharmacogenomic Testing (GeneSight / Genomind)

Pharmacogenomic testing helps identify how your genes affect your response to psychiatric medications. This can reduce trial-and-error prescribing and improve treatment outcomes.

At Light at the End PLLC, we use testing to:

• Optimize medication selection for ADHD, anxiety, depression, and mood disorders
   
• Minimize side effects
   
• Enhance treatment efficiency
   

Availability: Testing is offered to adults across Arizona via telehealth consultation.

Q1: What is pharmacogenomic testing?
A: It’s a genetic test that helps identify how your body may respond to psychiatric medications, reducing trial-and-error prescribing.

Q2: Who can benefit from testing?
A: Adults across Arizona considering or currently on medication for anxiety, depression, ADHD, or mood disorders.

Q3: Is the testing done in-person?
A: No, the test can be completed with a simple at-home sample, and results are reviewed during a telehealth consultation.

Q4: Will insurance cover pharmacogenomic testing?
A: Coverage varies by plan. We can help you check with your insurance or discuss self-pay options.